# Resume checkpoint — IL-1β/STAT3 + expanded-study session

*Checkpoint saved mid-project. All deliverables below are already artifacts; the workspace holds nothing unsaved that matters.*

## What was done this session

1. **IL-1β/STAT3 bulk meta-analysis, peri-lesional excluded.** Built a focused lesional-vs-normal (PP-vs-NN) two-group contrast on the IL-1β/inflammasome + STAT3/JAK-STAT modules (with IL-36, Th17, output context).
2. **Study-set expansion k=3 → k=4.** Screened all 23 human recount3 psoriasis studies; added **SRP065812** (16 healthy NN + 18 pre-treatment PP, dropped 18 post-adalimumab). Excluded **ERP110816** (all etanercept/anti-TNF, no timepoint field to isolate baseline). Final set: SRP035988, SRP165679, SRP126422, SRP065812 = 141 NN + 145 PP, all treatment-free. Same pipeline (filterByExpr→TMM→voom; DL random-effects meta).
3. **Isoform-by-cell-type: closed as infeasible.** GSE173706 is 10x droplet; short-read 3′/5′ tags cannot resolve STAT3α/β C-terminal splice per cell. Indirect ecological-correlation fallback (bulk STAT3β-PSI vs deconvolution proportions) documented but not run.
4. **Wrote a dedicated meta-analysis section** (not folded into the Scissor WHITEPAPER.md, which is a separate arm).

## Key scientific result

- **STAT3/JAK-STAT robustly up, confirmed by 4th cohort**: STAT3 +1.06, STAT1 +1.70, JAK3 +1.12, TYK2 +0.23 (all FDR<0.05, k=4). Tightest/most reproducible signal.
- **IL1B transcript is the least reliable panel gene**: +1.09, n.s., I²=94%, pulled down by the new cohort. Inflammasome machinery (CASP1, PYCARD, AIM2, CASP5, IL1RN) IS significant. IL-36 dominant (IL36A +9.0).
- **3 significance flips on adding study 4** (SOCS3, IL18, CXCL2) — all I²=95–98%; exposed genuine between-study disagreement, not signal loss. Large fold-changes shrank toward zero; all directions preserved.
- **Target-hypothesis takeaway**: STAT3/JAK-STAT is the druggable arm; IL-1β hypotheses should rest on inflammasome/output or IL-36, not IL1B expression.

## Key artifacts (latest version_ids)

- `IL1B_STAT3_expanded_analysis.md` — the writeup — 1ad8ca91-b750-4c59-9d81-0d997843d6eb
- `fig_il1b_stat3_NNvsPP_4study.png` — k=4 forest plot — 44e10919-2955-4b70-a327-02096b5a3de0
- `meta_de_PPvsNN_4study.csv` — genome-wide k=4 table — 1ec80908-9a53-4351-8900-a793b995dabd
- `meta_PPvsNN_k3_vs_k4_panel.csv` — k=3 vs k=4 comparison — 34f3b909-e18e-47cf-9746-25b87c801ebc
- `study_eligibility_PPvsNN.csv` — 23-study screen + decisions — 8099b3fa-80df-413a-870b-649451ed2dba
- `SRP065812_rse_clean.rds` — new study, clean 16 NN + 18 PP (workspace; re-fetchable via recount3)

## Open threads / next options

1. **Healthy-vs-uninvolved moderator model** — designed, endorsed, not run. Will be under-powered (only SRP165679 carries both control types). Report as exploratory.
2. **Re-render whitepaper formats** — Scissor WHITEPAPER.md is at md v4 (two-stage-design edits intact); HTML/PDF still old, deferred since earlier in session.
3. **STAT3 isoform ecological correlation** — the indirect fallback, if per-cell is wanted despite the 10x limitation.
4. **From prior HANDOFF (single-cell arm)**: Scissor full-census cluster run, compiled-Scissor cross-check, benchmarked deconvolution (deconvBenchmarking as Stage 1), sequence-level Sei-LLRA arm.
